Joshua Pinto - May 21, 2025 Form 4 Insider Report for Neumora Therapeutics, Inc. (NMRA)

Role
President
Signature
/s/ Michael Milligan, as Attorney-in-Fact for Joshua Pinto
Stock symbol
NMRA
Transactions as of
May 21, 2025
Transactions value $
$0
Form type
4
Date filed
5/23/2025, 04:42 PM
Previous filing
May 22, 2025
Next filing
May 30, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pinto Joshua President C/O NEUMORA THERAPEUTICS, INC., 490 ARSENAL WAY, SUITE 200, WATERTOWN /s/ Michael Milligan, as Attorney-in-Fact for Joshua Pinto 2025-05-23 0001992595

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NMRA Common Stock Gift $0 -13.2K -17.16% $0.00 63.8K May 21, 2025 Direct F1
transaction NMRA Common Stock Gift $0 +13.2K +9.5% $0.00 152K May 21, 2025 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 21 2025, the Reporting Person transferred 13,202 shares of Common Stock to a family limited liability company (the "Family LLC") in a transaction exempt from reporting pursuant to Rule 16a-13. The Reporting Person continues to exercise investment control over the Common Stock held by the Family LLC.
F2 Shares held by Maple DE Holdings LLC, which is the entity defined above as "Family LLC".